(IGXT)Mcap 28 M// Partnership THIS MONTH/1x Approved drug

[Biotechmaster]

THIS UNKNOWN GEM IS THE CHEAPEST STOCK WITH THE HIGHEST UPSIDE POTENTIAL IN THE COMPLETE BIOTECH SECTOR .DO YOUR OWN DD AND REALIZE THE MEGA MONSTER POTENTIAL ! GLTA


This Goldmine has a VERY LOW burn-rate of only $1.2 M a year means we have enuff cash untill 2014 EXCLUDING cpi-300 revenue and EXCLUDING upfront payments from upcoming partnerships BUT MORE IMPORTANT TO KNOW IS THAT WE WILL REACH PROFITABILITY THIS YEAR !!!

2x NDA filings for Migraine and Antipsychotic drugs this year which have much bigger market potential than current approved drug .

IGXT has NO DEBT and the Market cap of only 28 M is more than RIDICULOUS for this GOLDMINE .


Intelgenx (IGXT.OB)

Market Cap : $ 28 M
Cash: $ 3.3 M
Price : 0.60 $
NO DEBT

Shares Out : 45 M ( 23 M shares are held by Insiders + Institutions)


HEAVY BUYING BY INSTITUTIONS



Burn-rate only 300K per Q / IGXT has 3.3 M cash / Do the Math !




PARTNERDEAL THIS MONTH



Sales Potential for approved drug CPI-300



Profitability and 2 new NDA filings in 2012



MONSTER PIPELINE including a Blockbuster



Biomedreport Article from Nov 2011